Library / regulatory-reference
Angola: Regulatory Agency for Medicines and Health Technologies (ARMED)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Regulatory Agency for Medicines and Health Technologies, known by its Portuguese initials ARMED, is Angola's national regulator for human medicines and health technologies. It was created by presidential decree as a public establishment with administrative, patrimonial and financial autonomy.
Angola is one of Africa's larger oil-economy markets, almost entirely import-supplied for medicines, so the agency's registration and licensing decisions govern essentially the whole national supply.
How products enter the market
Medicines require registration after evaluation of quality, safety and efficacy, and the agency licenses pharmaceutical activities including importation, distribution and retail pharmacies.
Its mandate spans regulation, licensing, inspection and control across medicines and health technologies, with supervision of the market after authorization.
Regional and international role
As one of the region's younger regulators, the agency's institution-building is watched in Lusophone and Southern African regulatory circles, where several countries are consolidating medicines oversight in parallel.
Its online licensing services mark an early digitalization step that regional peers are also pursuing.
Using this profile
The agency publishes licensing information and announcements in Portuguese through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: ARMED illustrates the newly consolidated Lusophone regulator: a young autonomous agency taking over medicines oversight from ministry directorates, with digital licensing from the start.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.